BREATHE UM Central Site Startup

Acute viral bronchiolitis is the most common reason for hospitalization of infants in the United States. Children hospitalized for bronchiolitis are at high risk for adverse respiratory outcomes for which there are no effective secondary prevention strategies. Improvement of indoor air quality may improve post-bronchiolitis health outcomes. The primary objective of the Bronchiolitis Recovery through HEPA (BREATHE) clinical trial is to determine if use of a HEPA filtration home intervention reduces the respiratory symptom burden over 24 weeks compared to a use of a control filter. The UM Central site is leading management of all equipment and indoor air quality data for BREATHE.